Pricing and reimbursement of pharmaceuticals 3.53. Set the maximum price of the first generic introduced in the market to 60% of the branded product with similar active substance. [Q3-2011]
3.54. Revise the existing reference-pricing system based on international prices by changing the countries of reference to the three EU countries with the lowest price levels or countries with comparable GDP per capita levels. [Q4-2011] link
PORTUGAL: Memoradum of understanding on specific economic policy conditionality, 03.05.11
«Greece, in its response to economic crisis in 2010, introduced a series of new regulations to decrease pharmaceutical prices. After initial temporary price cuts, causing two pharmaceutical companies to withdraw their products (Watson, 2010), Greece implemented an IRP system where prices are reviewed and set three times per year based on the average of the three lowest prices available in 22 EU countries (the EU 27 excluding Denmark, Estonia, Malta, and Sweden) leading to an average price of the reviewed products Reduction of 20% (IMS 2010). "
Pharmaceutical pricing in Europe, February 2011
E-Paddle! Pharmaceutical pricing in Europe, February 2011
0 comments:
Post a Comment